Longeveron (LGVN) Accounts Payables (2022 - 2026)

Longeveron (LGVN) recorded quarterly Accounts Payables of $293000.0 in Q1 2026, down 30.73% quarter-over-quarter from $423000.0 in Q4 2025, and down 20.16% on a YoY basis from $367000.0 in Q1 2025.

Longeveron (LGVN) Accounts Payables (2022 - 2026) Analysis & Trends

Longeveron's Accounts Payables history runs 5 years deep, the most recent figure standing at $293000.0 for Q1 2026.

  • In Q1 2026, Accounts Payables fell 20.16% year-over-year to $293000.0; the TTM figure through Mar 2026 stood at $293000.0 (down 20.16% YoY), while the FY2025 annual figure was $423000.0, up 327.27% from the prior year.
  • Accounts Payables was $293000.0 for Q1 2026 at Longeveron, down from $423000.0 in the prior quarter.
  • In the past five years, Accounts Payables ranged from a high of $1.8 million in Q4 2022 to a low of $99000.0 in Q4 2024.
  • Historically, Accounts Payables has averaged $833384.6 across 5 years, with a median of $700000.0 in 2025.
  • The sharpest annual moves came in 2024 and 2025: Accounts Payables sank 84.48% in 2024, then jumped 327.27% in 2025.
  • A 5-year view of Accounts Payables shows it stood at $1.8 million in 2022, then slumped by 63.56% to $638000.0 in 2023, then tumbled by 84.48% to $99000.0 in 2024, then surged by 327.27% to $423000.0 in 2025, then sank by 30.73% to $293000.0 in 2026.
  • The last three Accounts Payables figures came in at $293000.0 (Q1 2026), $423000.0 (Q4 2025), and $1.1 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Accounts Payables (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - 1.05 Mn
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 83.00 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - 8.64 Mn
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 489.30 Mn
9 Abivax 91.96 Bn 91.96 Bn - 34.55 Mn
10 Longeveron 20.35 Bn 20.33 Bn 264,000.00 293,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 293,000.00
Dec 31, 2025 423,000.00
Sep 30, 2025 1.08 Mn
Jun 30, 2025 700,000.00
Mar 31, 2025 367,000.00
Dec 31, 2024 99,000.00
Sep 30, 2024 887,000.00
Jun 30, 2024 600,000.00
Mar 31, 2024 1.47 Mn
Dec 31, 2023 638,000.00
Sep 30, 2023 829,000.00
Jun 30, 2023 1.70 Mn
Dec 31, 2022 1.75 Mn